国药控股湖南衡阳医疗器械有限公司60%股权 |
| 时间：2022-04-27 09:53:59 来源： 作者： |
| {"holderlist":{"utrgcemsshareholder":[{"createtime":"2022-04-27 09:53:59.000","id":"64376-104977","holderno":"1","pch":"104977","lastupdatetime":"2023-01-29 00:12:08.864","holdername":"国药控股湖南有限公司","projectid":"203610","holdingratio":"60","objectid":"203610","holderid":"64376","recordtype":"A00001"}, {"createtime":"2022-04-27 09:53:59.000","id":"64377-104977","holderno":"2","pch":"104977","lastupdatetime":"2023-01-29 00:12:08.864","holdername":"湖南省湘富邦企业项目管理有限公司","projectid":"203610","holdingratio":"40","objectid":"203610","holderid":"64377","recordtype":"A00001"}]},"sellerlist":{"utrgcemsseller":[{"hqcode":"91110000100005888C","authorizefilename":"关于同意转让国药控股湖南衡阳医疗器械有限公司60%股权的批复","sellerid":"12805","zonezw":"长沙市开福区金霞开发区华宁路299号","approvalagency":"集团（控股）公司","createtime":"2022-04-27 09:53:59.000","id":"12805-104977","estabdate":"2001-06-21","sellertype":"A11001","economynature":"A19002","gyfgylx":"0","sellername":"国药控股湖南有限公司","projectid":"203610","regcapcurrency":"RMB","recordtype":"A00001","monitorname":"A02001","legalcontact":"郭磊","sellerstockpercent":"60","pch":"104977","industrycodezw":"批发业","sharesunit":"1","managerscale":"A04001","gyzbczlx":"2","sellpercent":"60","zonecountyzw":"开福区","objectboss":"伊欣","hqname":"中国医药集团有限公司","authorizefiletype":"A07004","zonecityzw":"长沙市","industrycode":"F51","authorizeunit":"国药控股股份有限公司","decisionfiletype":"A07002","sellercode":"91430000727983896X","lastupdatetime":"2023-01-29 00:12:08.852","authorizedate":"2022-03-24","zoneprovincezw":"湖南省","economytype":"A05003","licenseenddate":"2999-12-31","regcapital":"52000","legalcontactphone":"15901373138","registeredcapital":"52000.00万元(人民币)","zone":"430105"}]},"utrgcemsproject":{"projecttype":"G3","projectcode":"G32022BJ1000153","publishdate":"2022-04-28","sfplzcpgqk":"0","procontactmobile":"010-83143018","objectprice":"1237.494万元","recordtype":"A00001","pch":"104977","workingday":"22","bdsfsycmcp":"0","procontact":"李婷","shtgsj":"2022-04-27 16:31:37","sfwwxs":"1","procontactphone":"15810156533","bjhlpuburl":"https://otc.cbex.com/cgq/detail/203610.html","businessstatus":"A01001","expiredate":"2023-02-02","object":"国药控股湖南衡阳医疗器械有限公司60%股权","id":"12987-104977","membermobile":"13911373301","createtime":"2022-04-27 09:53:59.000","zonecity":"430400","memberbroker":"任经理","relatedprocode":"G32022BJ1000153-0","workingxs":"120秒","projectid":"203610","membercode":"J0032","istransferofctrl":"T","notcollectdesc":"延长信息披露：不变更信息披露内容，按照5个工作日为一个周期延长，直至征集到意向受让方。","sfxshybl":"1","workingrmb":"万元","isbind":"F","deptcontactmobile":"010-66295582","memberorg":"北京汇通行投资顾问有限公司","releaselevel":"0","duration":"20","lastupdatetime":"2023-01-29 00:12:08.830","deptcontact":"陈列"},"utrgcemsobject":{"zonecounty":"湖南省衡阳市雁峰区白沙洲工业大道30号湘梦智谷E栋三层302","evaluatedebt":"320.86","stmtprofit":"3.92","approvedate":"2021-12-29","stmtnetprofit":"2.94","economynature":"A19002","stmtdebt":"198.61","paidfunding":"2000.00万元(人民币)","evaluateasset":"2383.34","recordtype":"A00001","auditequity":"2030.83","auditearning":"78.21","pch":"104977","auditunit":"安永华明会计师事务所（特殊普通合伙）长沙分所","industrycodezw":"批发业","audityear":"2021","sellpercent":"60","bookdebt":"320.86","zonecountyzw":"雁峰区","stmtgrossprofit":"3.92","auditdebt":"296.74","zonecityzw":"衡阳市","decisionfiletype":"A07003","evaluateunit":"上海东洲资产评估有限公司","objectid":"203610","registeredcapital":"2000.00万元(人民币)","bookequity":"2061.08","evaluateequity":"2062.49","auditgrossprofit":"-123.56","employeequantity":"2","auditprofit":"-123.56","objectevaluatevalue":"1237.494","approveunit":"中国医药集团有限公司","stmttype":"月报","stmtequity":"2033.77","objectname":"国药控股湖南衡阳医疗器械有限公司","id":"12987-104977","createtime":"2022-04-27 09:53:59.000","estabdate":"2018-08-22","zonecity":"430400","hascontainground":"F","projectid":"203610","bookasset":"2381.93","stmtasset":"2232.38","auditasset":"2327.56","auditnetprofit":"-125.5","managerscale":"A04002","businessscope":"一类、二类、三类医疗器械的销售。（依法须经批准的项目，经相关部门批准后方可开展经营活动）","zoneprovince":"430000","objectboss":"刘杨","stmtdate":"2022-02-28","industrycode":"F51","objectcode":"91430400MA4PUBM51N","lastupdatetime":"2023-01-29 00:12:08.857","zoneprovincezw":"湖南省","economytype":"A05003","evaluatedate":"2021-06-30","zone":"430406"},"utrgcemspubinfo":{"importantinfo":"其他详见交易所备查文件。","ypsj":"2023-01-29 00:01:00","moneypaytype":"一次性支付","baildate":"意向受让方经资格确认后3个工作日内交纳。","createtime":"2022-04-27 09:53:59.000","id":"12987-104977","isbail":"1","hasbuyintent":"F","biddingmethod":"多次报价","sellconditions":"1、意向受让方须在受让资格确认后3个工作日内支付371万元交易保证金至北交所指定账户（以到账时间为准）。\n2、若挂牌期满只产生一家未放弃优先购买权的原股东为意向受让方，则本项目采取协议转让方式成交；除未放弃优先购买权的原股东之外：（1）若挂牌期满只产生一家符合条件的意向受让方，则该意向受让方经一次报价后进入征询原股东环节：原股东行权的，该意向受让方交纳的保证金自原股东行权之日起3个工作日内无息返还；原股东放弃行权的，该意向受让方交纳的保证金直接转为转让价款的一部分；（2）若挂牌期满产生两家及以上符合条件的意向受让方，各意向受让方交纳的保证金转为竞价保证金，该项目采取网络竞价多次报价方式确定最高报价方后进入征询原股东环节：原股东行权的，最高报价方交纳的保证金自原股东行权之日起3个工作日内无息返还；原股东放弃行权的，最高报价方交纳的保证金直接转为转让价款的一部分，其余意向受让方所交纳的保证金在最高报价方被确定之日起3个工作日内无息返还。\n3、若非转让方原因，如意向受让方存在以下任何一种情形，转让方有权扣除该意向受让方的全部交易保证金：（1）意向受让方提出受让申请并经资格确认后单方撤回受让申请的；（2）产生两家及以上符合条件的意向受让方时未参加后续竞价程序的；（3）在竞价程序中以挂牌价格为起始价格，各竞买人均不应价的；（4）在被确定为受让方后未按约定时限与转让方签署《产权交易合同》的或未按约定时限支付交易价款的；（5）意向受让方存在其他违反交易规则、挂牌条件的。\n4、本项目挂牌公告期即为尽职调查期，意向受让方递交受让申请并且交纳交易保证金，即视为已经详细阅读并完全认可本转让标的披露的内容，已经完成对本项目的全部尽职调查，并依据该等内容以其独立判断决定自愿全部接受产权转让公告之内容。\n5、意向受让方须书面承诺：（1）意向受让方在被确认为受让方后，须在5个工作日内与转让方签订《产权交易合同》，并在合同签订后5个工作日内将剩余交易价款和交易服务费一次性交纳至北交所指定银行账户；（2）同意北京产权交易所在出具产权交易凭证后3个工作日内将全部交易价款一次性划转至转让方指定账户。（3）同意在被确定为受让方后，及时办理标的企业公司名称变更，经变更后的新标的企业名称不再使用\u201c国药控股\u201d、\u201c国药\u201d字号，不再继续使用\u201c国药控股\u201d、\u201c国控\u201d、\u201c国药\u201d名称、品牌、标识等开展任何生产经营活动。（4）知悉并认可《职工安置方案》（置北交所备查）全部内容。","projectid":"203610","employeesettle":"T","recordtype":"A00001","pch":"104977","pubexchangetype":"A10004","announcemethod":"A16002","buyerpostulate":"1、意向受让方应为依法设立并有效存续的企业法人、非法人组织或具有完全民事行为能力的自然人。\n2、意向受让方应具有良好的财务情况和支付能力。\n3、意向受让方应具有良好的商业信用。\n4、国家法律行政法规规定的其他条件。","lastupdatetime":"2023-01-29 00:12:08.864","projectlinkurl":"https://otc.cbex.com/cgq/detail/203610.html","giveuppriority":"F","ismixed":"0","pubid":"203610","bailprice":"371"}} |
|
|
|
